New Views of Ovarian Carcinoma Types: How Will This Change Practice?

作者: Martin Köbel , Robert J. Kurman , Jeffrey D. Seidman

DOI: 10.1007/978-0-85729-910-9_3

关键词:

摘要: Ovarian carcinomas are heterogeneous, comprised of five different cell types: high-grade serous, low-grade endometrioid, clear cell, and mucinous carcinoma. High-grade serous carcinoma causes the vast majority ovarian cancer deaths. This classification correlates with a variety distinctive clinical, epidemiological, molecular, behavioral features. type-specific approach is valuable framework for understanding biology investigating novel treatment approaches. An alternative, complementary provided by dualistic model which divides into type I II tumors. Type arise from well-characterized precursor lesions (endometriosis atypical proliferative (borderline) tumors), present in low stage, have an indolent behavior (endometrioid, mucinous, carcinomas, most carcinomas). tumors advanced stage appear to progress rapidly (high-grade A body literature now converging on consensus that intraepithelial fallopian tube. These data form basis our new conceptual “ovarian cancer” ultimately hoped improve lead effective screening prevention strategies.

参考文章(78)
Peter Devilee, Fattaneh A. Tavassoli, Pathology and Genetics of Tumours of the Breast and Female Genital Organs World Hhealth Organization Classification of Tumours. ,(2003)
Alicia A Tone, Shannon Salvador, Sarah J Finlayson, Anna V Tinker, Janice S Kwon, Cheng-Han Lee, Trevor Cohen, Tom Ehlen, Lee M, Mark S Carey, Heywood M, Judith Pike, Paul J Hoskins, Gavin C Stuart, Kenneth D Swenerton, David G Huntsman, C Blake Gilks, Dianne M Miller, Jessica N McAlpine, None, The role of the fallopian tube in ovarian cancer. Clinical advances in hematology & oncology. ,vol. 10, pp. 296- 306 ,(2012)
Ie-Ming Shih, Robert J. Kurman, Ovarian Tumorigenesis : A Proposed Model Based on Morphological and Molecular Genetic Analysis American Journal of Pathology. ,vol. 164, pp. 1511- 1518 ,(2004) , 10.1016/S0002-9440(10)63708-X
Steve E Kalloger, Martin Köbel, Samuel Leung, Erika Mehl, Dongxia Gao, Krista M Marcon, Christine Chow, Blaise A Clarke, David G Huntsman, C Blake Gilks, Calculator for ovarian carcinoma subtype prediction Modern Pathology. ,vol. 24, pp. 512- 521 ,(2011) , 10.1038/MODPATHOL.2010.215
Anna V. Yemelyanova, Russell Vang, Kara Judson, Lee-Shu-Fune Wu, Brigitte M. Ronnett, Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. The American Journal of Surgical Pathology. ,vol. 32, pp. 128- 138 ,(2008) , 10.1097/PAS.0B013E3180690D2D
Siân Jones, Tian-Li Wang, Ie-Ming Shih, Tsui-Lien Mao, Kentaro Nakayama, Richard Roden, Ruth Glas, Dennis Slamon, Luis A. Diaz, Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculescu, Nickolas Papadopoulos, Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma Science. ,vol. 330, pp. 228- 231 ,(2010) , 10.1126/SCIENCE.1196333
Martin Köbel, Steve E. Kalloger, Jennifer L. Santos, David G. Huntsman, C. Blake Gilks, Kenneth D. Swenerton, Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications Gynecologic Oncology. ,vol. 116, pp. 50- 56 ,(2010) , 10.1016/J.YGYNO.2009.09.029